INTRODUCTION
It has become increasingly clear that the interactions between extracellular matrix (ECM) 1 proteins and integrins, their cognate cell surface receptors, mediate cell adhesion, but also engender signals that participate in cell survival (1) . It has been shown that insufficient or inappropriate cell-ECM interactions cause apoptosis, previously designated anoikis (1) . This mechanism of integrin-dependent cytoprotection is operative against a variety of death-promoting stimuli, acting through the intrinsic (mitochondrial) or extrinsic (death receptor) apoptotic pathway and involving growth factor withdrawal (2-5), exposure to cytotoxic drugs (6,7) and ligation of death receptors (8, 9) . Critical signaling intermediates involved in integrin-dependent cell survival have been identified and integrin-mediated adhesion to the ECM stimulates the production of PI(3,4)P 2 and PI(3,4,5)P 3 (10, 11) , association of the p85 PI 3-kinase subunit with focal adhesion kinase (FAK) (12) and AKT activation (10, 11) . In turn, active AKT interferes with the apoptotic machinery by phosphorylating thus sequestering proapoptotic Bcl-2 family protein BAD, by inactivating members of the forkhead family of transcription factors, and by promoting NF-kB-dependent cytoprotection via transcriptional activation of a plethora of downstream target genes (13) .
The effector molecules involved in integrin-dependent cell survival have not been completely elucidated. Engagement of fibronectin through α 5 β 1 and α v β 1 and of vitronectin through α v β 3 integrins has been associated with up-regulation of anti-apoptotic Bcl-2, and Bcl-2 protection from apoptosis induced by serum deprivation (2, 14) . Whether other cytoprotective mechanisms for integrin-dependent cell survival exist in normal or tumor cells has not been determined. In addition to the Bcl-2 family of cell death regulators, a second group of inhibitor of apoptosis (IAP) proteins has been recently identified (15) . Survivin, a member of the IAP family of proteins, is expressed during embryonic and fetal development but undetectable in most normal adult tissues (16) . However, survivin becomes the fourth most expressed transcript in human cancer (17) , where it correlates with a more aggressive and disseminated disease, and reduced overall survival (18) . Several studies have shown that survivin expression inhibits cell death induced by various apoptotic stimuli in vitro (19) as well as in vivo (18, 20) . Adenocarcinoma of the prostate is the most common malignancy in men and the second leading cause of cancer-related deaths in the United States (21) . Evolution from a localized to an invasive, fatal disease is accompanied by progression from an androgen-dependent to an androgen-independent state (22) and by the emergence of apoptosis-resistant cells within primary and/or metastatic tumors. Although several anti-cancer strategies have been shown to exert their cytotoxic effect via activation of an apoptotic program, the limited efficacy of anticancer drugs against epithelial neoplasms implies the ability of tumor cells to raise their anti-apoptotic threshold, thus evading cell death.
Despite growing evidence regarding the important role of integrins in tumorigenesis and in resistance to chemotherapeutic drugs, the molecular mechanisms underlying integrin-mediated survival signaling in cancer cells are not completely understood. In this study, we demonstrate that cell adhesion to fibronectin via β 1 integrins regulates survivin protein levels and provides protection against death-induced stimuli via AKT activation. Conversely, inhibition of survivin function reverses the cytoprotective effect of ECM proteins and results in tumor cell apoptosis.
We also show that the β 1A integrin cytodomain is essential for cytoprotection against deathinducing stimuli in a survivin-dependent manner. We conclude that the activation of survival pathways mediated by integrins and survivin may contribute to drug-resistance in cancer cells.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents-The following antibodies were used: a rabbit antibody to survivin (Novus Biologicals, Littleton, CO) was characterized in previous studies (23) ; rabbit affinitypurified IgG to ERK1 and 2 (Santa Cruz, Santa Cruz, CA); rabbit affinity-purified IgG to XIAP (Santa Cruz); rabbit affinity-purified IgG to caspase-3 (BD Transduction Laboratories, San Diego, CA); rabbit affinity-purified IgG to phospho-(Ser/Thr) AKT substrates (Cell Signaling, Beverly, MA); monoclonal antibody (mAb) to survivin (23) Running title: Fibronectin -mediated regulation of survivin expression 5 rabbit IgG and mouse IgG were purchased from Sigma, and used as controls. Fibronectin and vitronectin were purified from human plasma and serum, respectively, as described previously (24, 25) . Reagents used in this study were: Z-VAD-fmk (Enzyme Systems Products, Livermore, CA), cycloheximide (CHX; Sigma), tumor necrosis factor (TNF)α (R&D Minneapolis, MN), actinomycin D (Act D; Sigma), etoposide (Sigma), propidium iodide (Sigma), RNAse A (Roche) and bovine serum albumin (BSA; Sigma). . LNCaP, LNCaP-LN3 and PC3 cells were cultured as described previously (27) . RWPE-1 cells were grown in keratinocyte-serum free medium (Life Technologies) supplemented with 5 ng/ml epidermal growth factor (EGF; Life Technologies), and 0.05 mg/ml bovine pituitary extract (Life Technologies). To obtain PC3 stable cell lines expressing either β 1C or β 1A integrins under the control of a tetracycline regulated promoter, chimeric cDNAs consisting of the chicken β 1 extracellular and transmembrane domain and either human β 1C or human β 1A cytodomain sequences were generated by PCR-driven splice overlap extension (28) . These chimeric constructs allow one to distinguish between endogenous β 1 integrin and exogenous β 1C and β 1A integrin variants in human cells. PCR reactions were performed using an automatic thermal cycler (Perkin-Elmer Cetus, Foster City, CA). The conditions used for the PCR reactions were: denaturation at 95ºC for 1 min, annealing at 45ºC for 1 min and extension at 72ºC for 1 min.
Cells-RWPE-1,
Thirty cycles of amplification were used. The amplification was performed in 1x Vent bp chicken/human β 1A and the 834 bp chicken/human β 1C chimeras were excised from pCR2.1 using ClaI and SpeI and subcloned into pTet-Splice expression vector (32) . The resulting constructs were digested with SalI and ClaI to allow ligation of a DNA fragment corresponding to nucleotides 1 to 1787 of the chicken β 1 extracellular domain which was isolated from pECE-β 1 (kindly provided by Dr. Hynes, MIT, MA) using SalI and ClaI restriction enzymes. The chimeric constructs (pTet-chicken/human β 1C and pTet-chicken/human β 1A ) were sequenced by the dideoxynucleotide method to confirm the nature of the chimeric inserts. PC3 cells were electroporated as described (33) using either 100 µg pTet-chicken/human β 1C , pTetchicken/human β 1A , or pTet-Splice along with 10 µg pTet-tTA. Neomycin-resistant cells were selected using medium containing 0.2 mg/ml G418 (Life Technologies). G418-resistant clones were isolated and screened for cell surface expression of either chicken/human β 1C or chicken/human β 1A integrin by FACS using W1B10, monoclonal antibody against the extracellular domain of chicken β 1 integrin, or 12CA5, as a negative control, as described (34) .
Analysis of Survivin and Bcl-2 Expression by
Immunoblotting-Subconfluent RWPE-1, LNCaP, LNCaP-LN3 and PC3 cells were lysed as described (35) . In some experiments, subconfluent PC3 and LNCaP cells were serum-starved for 24 h, detached using 0.05% trypsin/0.53 mM EDTA (Life Technologies), and washed three times with serum-free medium. PC3 (4 x 10 5 ) and LNCaP
(1 x 10 6 ) cells were then plated onto 60 mm petri dishes coated with 10 mg/ml BSA, 5 µg/ml fibronectin, or with 10 µg/ml vitronectin, for 8 and 24 h in serum-free medium in the absence or in the presence of either 20 µg/ml Act D or of 10 µg/ml CHX. Cells were then lysed as described above. Protein content in each lysate was quantitated using the BCA protein assay reagent by guest on September 1, 2017 http://www.jbc.org/
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Running title: Fibronectin -mediated regulation of survivin expression 7 (Pierce, Rockford, IL). Samples were heated at 100°C for 5 min and separated by electrophoresis on a 12-15% SDS polyacrylamide gel, and transferred onto Immobilon-P membrane (Millipore Corp, Bedford, MA). Expression of survivin, and Bcl-2 was analyzed by immunoblotting using 1 µg/ml of the polyclonal antibody to survivin, and 1 µg/ml mAb to Bcl-2, respectively, as described (35) . Rabbit affinity-purified antibody to ERK1/2 was used to control for protein loading as described (35) .
Tissue Specimen Procurement and Immunohistochemistry-Specimens from fifty-three human radical prostatectomies performed for prostatic adenocarcinoma at the Yale-New Haven Hospital (New Haven, CT) were processed according to Review Board approved protocols. Hematoxylin and eosin sections from all specimens were evaluated microscopically to assess tissue integrity and preservation.
Sections from formalin-fixed, paraffin-embedded specimens were immunostained as described (33) using either 60.1 mAb to survivin (1:1000 dilution) or mAb 1C10 as control antibody (1:1000 dilution).
Plasmids, Transient Transfections, and Determination of Apoptosis-
The survivin (C84A) mutant or survivin antisense cDNA were subcloned into pEGFPc1 (36, 37, 39) . Replication-deficient adenoviral constructs encoding wild-type survivin (pAd-survivin), the survivin T34A mutant (pAd-T34A) or control GFP (pAd-GFP) were generated using the pAd-easy system as described previously (37) . The pCMV6 plasmids containing HA-tagged AKT K179M mutant (dn AKT) or wild type (wt) AKT were a kind gift of Dr. Franke (Columbia University, NY) (38) . (pAd-survivin), the phosphorylation-deficient survivin Thr34→Ala dominant negative mutant (pAd-T34A) or control pAd-GFP have been described previously (37) . With this protocol, there was no generation of replication competent adenoviral particles. PC3 cells (1.5 x 10 6 ) in 100 mm plates were infected with pAd-GFP, pAd-survivin or pAd-T34A at moi of 50-100 for 24 h at 37°C. Cells were then detached using 0.05% trypsin/0.53 mM EDTA, washed 3 times with serum-free medium and plated (4 x 10 5 ) onto 60 mm petri dishes coated with either 10 mg/ml BSA or with 5 µg/ml fibronectin for 8 h in serum-free medium. Cells were then treated with 150 ng/ml TNFα plus 3 µg/ml CHX for an additional 42 h at 37°C. Cells (floating plus attached cells)
were fixed in 70% ethanol and GFP-expressing cells were analyzed for DNA content as described above. PC3-β 1C and PC3-β 1A stable cell lines were cultured for 72 h in growth medium either in the absence or in the presence of 1 µg/ml tetracycline. Cells were infected with pAd-GFP or pAdsurvivin at moi of 50-100 for 24 h at 37°C during the last 24 h of the 72-h culture. Cells were harvested using 0.05% trypsin/0.53 mM EDTA, and then plated (4 x 10 5 ) onto 60 mm petri dishes coated with 10 mg/ml BSA for 8 h in serum-free medium. Cells were then treated with 150 ng/ml TNFα plus 3 µg/ml CHX for an additional 20-24 h at 37°C and then analyzed for DNA content as described above.
Statistical Analysis-Group differences were compared using Student's t test. (Fig. 1A) . Immunohistochemical analysis of fifty-three human prostatic adenocarcinoma tissue specimens showed that survivin was expressed in glandular epithelium as well as in fibromuscular stromal cells (Fig. 1B) .
RESULTS

Survivin Targeting Causes Spontaneous Apoptosis in PC3 Cells
Transfection of PC3 cells with GFP constructs expressing the dominant negative survivin, C84A
mutant (40), or survivin antisense cDNA resulted in the appearance of PC3 cells with hypodiploid (apoptotic) DNA content, as shown by propidium iodide staining (respectively, Fig. 2A and 3B) and caused spontaneous DNA fragmentation, as indicated by DAPI staining of GFP-expressing cells (Fig. 3A) . In time course experiments, expression of GFP-survivin C84A mutant or GFPsurvivin antisense cDNA resulted in progressively increased apoptosis with 60-65% of GFPexpressing cells exhibiting hypodiploid (apoptotic) DNA content four days after transfection (respectively, Fig. 2B and 3C ). Transfection of PC3 cells with survivin C84A mutant resulted in a 2-3-fold increase in caspase-3 activity, as determined by DEVD hydrolysis (Fig. 2C ) (40) .
Similarly, transfection of PC3 cells with survivin C84A mutant resulted in proteolytic cleavage of 116 kD caspase-dependent substrate, PARP, with generation of an 85 kD product (Fig. 2D) .
Preincubation of PC3 cells with Z-VAD-fmk entirely suppressed caspase-3 activity, and PARP cleavage induced by survivin targeting (Fig. 2, C and D) . These findings indicate that inhibition of survivin function in prostate cancer cells is sufficient to cause all the biochemical hallmarks of apoptosis including hypodiploid DNA content, caspase-3 activity and cleavage of caspase substrate(s). panel B, 3-fold increase in three experiments). PC3 cell adhesion to fibronectin is predominantly mediated by β 1 integrins, known to be expressed at high levels in these cells (27, 41 4C ). These results suggest that regulation of survivin levels by fibronectin occurs at transcriptional and translational levels. In addition, no changes in expression of anti-apoptotic Bcl-2 or XIAP were observed following cell adhesion to fibronectin at all time points examined (Fig. 4D, top panel and not shown) . However, adhesion of PC3 cells to vitronectin resulted in increased levels of Bcl-2 by Western blotting (not shown), in agreement with previous observations (7, 14) , whereas survivin expression was unchanged (Fig. 4E, top panel) . In conclusion, survivin levels in PC3 cells are up-regulated in response to cell adhesion to fibronectin. (Fig. 5, A and B) . At variance with these data, apoptosis induced by etoposide was not affected by cell adhesion to fibronectin (Fig. 5, A and C) .
Fibronectin Adhesion Increases Survivin Protein Levels in PC3 but not in LNCaP Cells
Fibronectin Adhesion Protects PC3 Cells from TNFa-Induced Apoptosis-To
Pretreatment with the caspase inhibitor Z-VAD-fmk abrogated apoptosis induced by both TNFα or etoposide (Fig. 5, A and B) , thus confirming the involvement of caspases in this apoptotic response. These data show that fibronectin-induced survival signaling results in protection from specific apoptotic stimuli.
Survivin Mediates the Anti-Apoptotic Effect of Fibronectin and Increases Survival of non-
Adherent Cells-To examine whether survivin is required for fibronectin protection against TNFα-induced apoptosis, we used a second survivin dominant negative mutant Thr34→Ala (37, 42) that (Fig. 7, B and C) . In contrast, expression of pAd-survivin in PC3-β 1C cells held in suspension was not able to rescue apoptosis triggered by TNFα (Fig. 7, B and C) . These data suggest that the β 1A cytodomain is necessary to protect cells from TNFα-induced apoptosis in a survivin-dependent manner.
Fibronectin Induces Survivin Expression via AKT -In epithelial cells, matrix attachment results in
activation of AKT and mediates integrin survival signaling (10, 11, 45) . This pathway acts as a general cell viability signal that may also involve increased survivin expression (46) . To resulted in up-regulation of Bcl-2 in CHO cells (2, 14) and that Bcl-2 prevents anoikis in prostate cancer cells (52) , whereas the levels of Bcl-2 were unchanged in response to fibronectin adhesion in myeloma cells (53) . We have found that PC3 cell adhesion to vitronectin up-regulates the levels of Bcl-2 (not shown), however we could not detect a significant change in the levels of Bcl-2 in response to fibronectin adhesion. The apparent discrepancy between our results and the aforementioned studies could be ascribed to the different cell types used.
To causally link the increased survivin expression by fibronectin adhesion to protection from apoptosis, we used a dominant negative survivin mutant, i.e. Thr34→Ala, that has shown promising anti-tumor efficacy for its ability to induce apoptosis and to enhance cell deathinducing stimuli in vitro and in a number of cancer models, in vivo (37, 42) . Consistent with these endogenous survivin levels appears likely due to the ability of these mutants to dimerize with wild type survivin and to exhibit accelerated clearance. This is reminiscent of the apoptotic response observed after loss of endogenous survivin levels by antisense oligonucleotide treatment, and enhancement of chemotherapy-induced cell death (40, 54) . It was recently reported that expression of survivin Thr34→Ala resulted in inhibition of cell proliferation, induction of apoptosis and catastrophic mitotic defects in 100% of expressing cells, thus potentially in agreement with the data presented here (55) . Surprisingly, however, the same authors argued that survivin Thr34→Ala mutant functioned to protect against various apoptotic stimuli, which contradicts their own data, and potentially reflects the highly artificial over-expression system used in these experiments.
Here, fibronectin-dependent adhesion effectively counteracted death receptor (i.e. TNFα)- detected by immunoblotting using 1 µg/ml rabbit affinity-purified antibody to survivin (top panels). B, graph represents means of relative levels of survivin expression ± standard error (SE).
The increase in survivin expression in cells plated on fibronectin is significantly higher than that of cells held in suspension (p=0.04). The bar graph shows the results of three independent experiments. C, PC3 cells were detached and cultured on petri dishes coated with 10 mg/ml BSA (S; lanes 1, 3 and 5) or with 5 µg/ml fibronectin (Fn; lanes 2, 4 and 6) for 24 h in serum-free medium in the absence (lanes 1 and 2) , or in the presence of either 20 µg/ml Act D (lanes 3 and 4) or 10 µg/ml CHX (lanes 5 and 6) at 37°C. Survivin expression was analyzed by immunoblotting as described in A. D, PC3 cells were treated as described in A and Bcl-2 expression was analyzed by immunoblotting using 1 µg/ml mAb to Bcl-2 (top panel). E, PC3 cells were detached and plated on petri dishes coated with 10 mg/ml BSA (S; lanes 1 and 3) or with 10 µg/ml vitronectin (Vn; lanes 2 and 4) for either 8 h (lanes 1 and 2) , or 24 h (lanes 3 and 4) at 37°C. Cells were lysed and survivin expression was detected as described above. Rabbit affinity-purified antibody 
